Journal of Carcinogenesis & Mutagenesis

Targeted Therapy: A Revolutionary Approach to Cancer Treatment

Taylor Jaraczewski^* Department of Medical Oncology, University of Amsterdam, Amsterdam, The Netherlands
^*Correspondence: Taylor Jaraczewski, Department of Medical Oncology, University of Amsterdam, Amsterdam, The Netherlands, Email:

Received: 30-Jul-2024, Manuscript No. JCM-24-26896; Editor assigned: 01-Aug-2024, Pre QC No. JCM-24-26896 (PQ); Reviewed: 15-Aug-2024, QC No. JCM-24-26896; Revised: 22-Aug-2024, Manuscript No. JCM-24-26896 (R); Published: 30-Aug-2024, DOI: 10.35248/2157-2518.24.S45.001

Description

The world of cancer treatment has been revolutionized by the development of targeted therapy. This innovative approach to cancer care has shown encouraging results in treating various types of cancer, including Adenocarcinoma pancreas. With the recent challenges posed by the COVID-19 pandemic, targeted therapy has emerged as a essential tool in the fight against cancer. This article describes the concept of targeted therapy, its benefits and its role in cancer care during the COVID era [1].

Targeted therapy

Targeted therapy is a type of cancer treatment that uses drugs or other substances to identify and attack specific cancer cells. Unlike traditional chemotherapy, which kills both cancerous and healthy cells, targeted therapy is designed to only target cancer cells, minimizing the damage to healthy cells. It works by targeting specific molecules that are involved in the growth, progression and spread of cancer cells. This targeted approach makes it a more effective and less toxic treatment option for patients [2,3].

The key to the success of targeted therapy lies in its ability to identify and target specific molecules that are present on the surface of cancer cells. These molecules, also known as targets or biomarkers, play a important role in the growth and survival of cancer cells. By targeting these molecules, targeted therapy can stop cancer cells from growing and dividing, leading to their death through a process called apoptosis.

The benefits of targeted therapy

Targeted therapy offers several advantages over traditional cancer treatments. As it only targets cancer cells, it causes fewer side effects, making it a more tolerable treatment option for patients. Additionally, targeted therapy can be combined with other treatments, such as chemotherapy and radiation, to further enhance its effectiveness. It also has the potential to overcome drug resistance, a common problem in cancer treatment [4].

Targeted therapy in cancer care during the covid era

The COVID-19 pandemic has had a significant impact on cancer care, with many patients experiencing delays in treatment and reduced access to healthcare facilities. In this scenario, targeted therapy has emerged as a game-changer. Its targeted approach and reduced side effects make it an ideal treatment option for patients who are at a higher risk of developing severe complications from COVID-19. It also allows for at-home treatment, reducing the need for hospital visits and minimizing the risk of exposure to the virus [5-8].

As our understanding of cancer continues to evolve, it's clear that targeted therapy will play an increasingly important role in the future of cancer treatment. This approach offers a more precise, effective and personalized alternative to traditional methods, with fewer side effects and a better overall quality of life for patients [9,10].

While targeted therapy may not be suitable for all cancer types, it's undoubtedly a game-changing treatment option that is already helping countless patients in their fight against cancer. As research and technology continue to advance, it's likely that targeted therapy will only become more effective in the years to come, offering hope to even more patients around the world.

Conclusion

Targeted therapy has revolutionized the field of cancer treatment, offering a more effective and less toxic approach to fighting cancer. Its ability to target specific molecules and minimize damage to healthy cells has made it a preferred option for many patients. With the added challenges posed by the COVID-19 pandemic, targeted therapy has emerged as an important tool in the fight against cancer, providing hope and a ray of light for patients battling this deadly disease.

References

1. Kandel I, Castelli M. Transfer learning with convolutional neural networks for diabetic retinopathy image classification. A review. Applied Sci. 2020;10(6):2021.

   [Crossref] [Google Scholar]

2. Deniz E, Sengur A, Kadiroglu Z, Guo Y, Bajaj V, Budak U. Transfer learning based histopathologic image classification for breast cancer detection. Health Inf Sci Syst. 2018;6:1-7.

   [Crossref] [Google Scholar] [PubMed]

3. Hussain M, Bird JJ, Faria DR. A study on CNN transfer learning for image classification. Adv Comp Intel Sys. 2018;5-7.

   [Google Scholar]

4. Faruk O, Ahmed E, Ahmed S, Tabassum A, Tazin T, Bourouis S, et al. A novel and robust approach to detect tuberculosis using transfer learning. J Healthc Eng. 2021.

   [Crossref] [Google Scholar] [PubMed]

5. Morid MA, Borjali A, Del Fiol G. A scoping review of transfer learning research on medical image analysis using imagenet. Comput Biol Med. 2021;128:104115.

   [Crossref] [Google Scholar] [PubMed]

6. Kim HE, Cosa-Linan A, Santhanam N, Jannesari M, Maro ME, Gans-landt T. Transfer learning for medical image classification: a literature review. BMC Med Imaging. 2022;22(1):69.

   [Crossref] [Google Scholar] [PubMed]

7. Rahman JF, Ahmad M. Detection of acute myeloid leukemia from periph- eral blood smear images using transfer learning in modified cnn architectures. Proceedings of International Conference on Information and Communication Technology for Developmen. 2023;447-459. Springer.

   [Google Scholar]

8. Afta MO, Awan MJ, Khalid S, Javed R, Shabir H. Executing spark bigdl for leukemia detection from microscopic images using transfer learning. IEEE. 2021;216–220.

   [Crossref] [Google Scholar]

9. Kumar D, Jain N, Khurana A, Mittal S, Satapathy SC, Senkerik R, et al. Automatic detection of white blood cancer from bone mar- row microscopic images using convolutional neural networks. IEEE. 2020; 8:142521-142531.

   [Crossref] [Google Scholar]

10. Liu Y, Long F. Acute lymphoblastic leukemia cells image analysis with deep bagging ensemble learning. Springer. 2019;113–121.

    [Crossref] [Google Scholar]